Aimee Deaton

Employment

• Alnylam Pharmaceuticals (United States) Associate Director, Human Genetics
  2019 - Present
• Amgen Inc
  2015 - 2019

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (26)

• Using human genetics to improve safety assessment of therapeutics
  Nature Reviews Drug Discovery 2023 93 citations DOI: 10.1038/s41573-022-00561-w
  +Save
• Activin E is a TGFβ ligand that signals specifically through activin receptor-like kinase 7
  2023 1 citation DOI: 10.1101/2023.09.25.559288
  +Save
• Rare loss of function variants in the hepatokine gene INHBE protect from abdominal obesity
  Nature Communications 2022 57 citations DOI: 10.1038/s41467-022-31757-8
  +Save
• GWAS of serum ALT and AST reveals an association of SLC30A10 Thr95Ile with hypermanganesemia symptoms
  Nature Communications 2021 7 citations DOI: 10.1038/s41467-021-24563-1
  +Save
• Rare coding variants in five DNA damage repair genes associate with timing of natural menopause
  2021 4 citations DOI: 10.1101/2021.04.18.21255506
  +Save
• Gene-level analysis of rare variants in 363,977 whole exome sequences identifies an association of GIGYF1 loss of function with type 2 diabetes
  2021 11 citations DOI: 10.1101/2021.01.19.21250105
  +Save
• GWAS of serum ALT and AST reveals an association ofSLC30A10Thr95Ile with hypermanganesemia symptoms
  2020 6 citations DOI: 10.1101/2020.05.19.104570
  +Save
• Author Correction: Phenotypes associated with genes encoding drug targets are predictive of clinical trial side effects
  Nature Communications 2019 4 citations DOI: 10.1038/s41467-019-10237-6
  +Save
• Phenotypes associated with genes encoding drug targets are predictive of clinical trial side effects
  Nature Communications 2019 109 citations DOI: 10.1038/s41467-019-09407-3
  +Save
• Rationalizing Secondary Pharmacology Screening Using Human Genetic and Pharmacological Evidence
  Toxicological Sciences 2019 33 citations DOI: 10.1093/toxsci/kfy265
  +Save